Haoxi Health Technology Ltd

Haoxi Health Technology Ltd (HAO) Stock Analysis

$2.070

+0.162 (+7.81%)At close

Loading chart…
High
2.100
Open
1.920
VWAP
2.03
Volume
18.29K
Mkt Cap
—
Low
1.920
Amount
37.12K
EV/EBITDA, TTM
0.00

Haoxi Health Technology Ltd is a China-based holding company principally engaged in the provision of online marketing solutions for customers. The Company's main business is the provision of one-stop advertising marketing solutions like online short video advertisements through its media partners, including planning, production, placement, and optimization of online advertisements. The co-operative media partners of the Company include media platforms (such as Toutiao and Tiktok) and authorized third-party agent media. The Company principally provides its advertising services to companies and customers in the healthcare field. The Company principally conducts its businesses in the domestic market.

AI analysis of Haoxi Health Technology Ltd (HAO)

Sell

Haoxi Health Technology Ltd is not a good buy right now due to its significant financial struggles and poor market performance. The current price is $1.92, and the stock has experienced a staggering year-to-date change of -99.93%. Additionally, the RSI is at 46.025, indicating a lack of strong momentum. The main risk is the company's negative net income of -2,655,086 USD in Q2 2026, which reflects ongoing financial instability.

Valuation Metrics

The current forward P/E ratio for Haoxi Health Technology Ltd (HAO) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
Overvalued
0.00
Undervalued
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued
0.00
Undervalued
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
Overvalued
0.00
Undervalued
0.00

Alphio AI Price Scenarios for HAO

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%HAO

$1.38

Scenario price

B

Base

Base · 50%HAO

$1.32

Scenario price

B

Bear

Bear · 25%HAO

$1.29

Scenario price

Events Timeline

2026-08-13 (ET)

20:00:00

Haoxi Health Technology Ltd Trading Halted, News Pending

2026-07-14 (ET)

07:01:00

Haoxi Health Technology signs AI marketing cooperation framework with Nova Media

2026-07-10 (ET)

13:30:00

Haoxi Health Technology to Sell 10M Shares at $0.40 Each

2026-05-20 (ET)

19:50:00

Haoxi Health Technology Ltd Trading Halted, News Pending

2026-05-11 (ET)

08:20:00

Haoxi Health Technology Enters $6.5M Securities Agreement with Investors

News

HAO FAQ — answered by Alphio AI

Haoxi Health Technology Ltd is a China-based holding company principally engaged in the provision of online marketing solutions for customers. The Company's main business is the provision of one-stop advertising marketing solutions like online short video advertisements through its media partners, including planning, production, placement, and optimization of online advertisements. The co-operative media partners of the Company include media platforms (such as Toutiao and Tiktok) and authorized third-party agent media. The Company principally provides its advertising services to companies and customers in the healthcare field. The Company principally conducts its businesses in the domestic market. It operates in the Consumer Cyclicals sector (ADVERTISING AGENCIES industry).

Haoxi Health Technology Ltd is not a good buy right now due to its significant financial struggles and poor market performance. The current price is $1.92, and the stock has experienced a staggering year-to-date change of -99.93%. Additionally, the RSI is at 46.025, indicating a lack of strong momentum. The main risk is the company's negative net income of -2,655,086 USD in Q2 2026, which reflects ongoing financial instability.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading